INVESTIGATIVE INTELLIGENCE BRIEF
ENTITY UNDER ANALYSIS: U.S. Representative Brett Guthrie (R-KY-2)
DATE OF ASSESSMENT: October 2, 2026
DATASET SUMMARY: 50 primary-source facts | 0 secondary-source facts | 0 pre-compiled inferential records | 150 documented connections (4 zero-result searches excluded)
1. CONFIRMED PRIMARY-SOURCE FACTS
A. Brett Guthrie (Electoral, Financial, and Asset Disclosures)
| Record ID / Date |
Domain |
Source Type |
Details |
| Fact 6 (2018-12-31) |
Assets / Wealth |
Congressional Disclosure |
2018 estimated net worth ranked 48th in the House at $7,663,010. Top assets included the Brett Guthrie Gift Trust (100% invested in Trace Die Cast, valued at $3,000,000) and the Lowell M Guthrie Irrevocable Trust ($3,000,000). |
| Fact 40 (2021-12-31) |
Business Affiliation |
Federal Disclosure |
Guthrie serves as an uncompensated board member and holds up to $10.5 million in equity in Trace Die Cast Inc. (family-owned aluminum die-casting business). The business received and had forgiven $4.3 million in federal Paycheck Protection Program (PPP) loans from the SBA. |
| Fact 3 (2024-12-31) |
Career Campaign Finance |
FEC Disclosures |
Career raised (2007–2024): $17,098,523. Top contributing industries: Health Professionals ($2,090,252), Pharmaceuticals/Health Products ($1,859,982), Health Services/HMOs ($832,211), and Lobbyists ($784,229). |
| Fact 2 (2024-12-31) |
2023–2024 Cycle Finance |
FEC Disclosures |
Raised $3,829,928. Breakdown: PAC contributions: 74.09% ($2,842,788); Large individual contributions: 24.90% ($955,493); Small individual contributions (<$200): 1.00% ($38,277); Candidate self-financing: $0. |
| Fact 4, 44 (2024-12-31) |
Sector Donations |
FEC Disclosures |
#1 recipient of pharmaceutical and health products industry donations among all congressional incumbents in the 2024 cycle, taking $507,000. |
| Fact 35 (2024-12-31) |
Top Donors (2024 Cycle) |
FEC Disclosures |
Top contributor: Eli Lilly & Co at $24,900 ($14,900 individual + $10,000 PAC). Others: Novocure Inc ($18,500), DISH Network ($18,200), BGR Group ($16,500), American Podiatric Medical Assn ($15,000). |
| Fact 36 (2024-12-31) |
Top Donors (Career) |
FEC Disclosures |
Top career contributor: Blue Cross/Blue Shield at $118,000 ($500 individual + $117,500 PAC). Others: AT&T Inc ($86,000), Brown-Forman Corp ($84,799), American Bankers Assn ($84,000), National Auto Dealers Assn ($82,500). |
| Fact 38 (2024-11-05) |
Endorsements |
Official Disclosures |
Endorsed in 2024 by AIPAC, Campaign for Working Families, Huck PAC, National Rifle Association (NRA), National Right to Life Committee, and Donald Trump. |
| Fact 5 (2025-03-31) |
Party Transfers |
FEC / Campaign Disclosures |
Transferred $2.5 million from his campaign committee to the National Republican Congressional Committee (NRCC), the highest transfer among 11 key House committee leaders examined by Issue One (representing >50% of his committee's total spending). |
| Fact 37 (2025-07-15) |
Q2 2025 Fundraising |
FEC Disclosures |
Disclosed $1.0 million in new fundraising in Q2 2025 FEC filing, with 46.7% sourced from individual donors. |
| Fact 34 (2025-09-30) |
Committee Leadership |
FEC Disclosures |
Ascended to Chair of the House Energy and Commerce Committee in January 2025. Tripled fundraising pace; PAC receipts grew from $651,800 (Jan–Sep 2023) to $1.6 million (Jan–Sep 2025), including contributions from ~100 PACs that had never previously donated to him. |
B. Legislative Voting Record and Public Statements
| Record ID / Date |
Measure / Event |
Source Type |
Details |
| Fact 50 (2011-01-19) |
H.R. 2 |
Roll Call Vote |
Voted Yea on Repealing the Job-Killing Health Care Law Act (full repeal of the Affordable Care Act). |
| Fact 45 (2017-05-04) |
H.R. 1628 |
Roll Call Vote |
Voted Yea on American Health Care Act (ACA repeal and replace; projected by CBO to cause 23 million Americans to lose coverage). |
| Fact 46 (2022-03-31) |
H.R. 6833 |
Roll Call Vote |
Voted Nay on Affordable Insulin Now Act (capping insulin copays at $35/month for insured patients/seniors; passed House 232–193). |
| Fact 39 (2022-08-25) |
Student Debt Statement |
Official Statement |
Stated via Twitter/X: "President Biden's taxpayer-funded student loan debt cancellation plan is a bribe to score political points ahead of the election at the expense of Americans who decided to pursue careers that didn't require taking on student debt or who worked hard to pay off their debt already." |
| Fact 43, 49 (2024-01-31) |
H.R. 7174 (EPIC Act) |
Roll Call / Sponsorship |
Sponsored H.R. 7174 to extend the exemption period from Medicare drug price negotiation for small-molecule drugs to match biologics, altering Inflation Reduction Act provisions. |
| Fact 42, 47 (2025-02-25) |
H.Con.Res. 14 |
Roll Call Vote |
Voted Yea on the FY 2025 Budget Resolution, advancing reconciliation instructions directing the Energy and Commerce Committee to cut $880 billion, predominantly targeted at Medicaid. |
| Fact 41, 48 (2025-07-03) |
H.R. 1 |
Roll Call Vote / Statement |
Voted Yea on the One Big Beautiful Bill Act (passed 218–214), permanently extending 2017 tax cuts and executing $880 billion in Medicaid-related spending reductions. Floor statement: "I rise in support of the One Big Beautiful Bill Act... to protect health care for our most vulnerable Americans." |
| Fact 9 (2025-09-09) |
H.R. 5143 |
Roll Call Vote |
Voted Yea on District of Columbia Policing Protection Act (overriding local D.C. governance on vehicular pursuit standards). |
| Fact 7 (2025-09-11) |
H.R. 3015 |
Roll Call Vote |
Voted Yea on National Coal Council Reestablishment Act (reconstituting federal coal advisory board). |
| Fact 8 (2026-02-25) |
H.J.Res. 139 |
Roll Call Vote |
Voted Yea on constitutional Balanced Budget Amendment. |
| Fact 10 (2026-02-26) |
H.R. 6409 |
Roll Call Vote |
Voted Yea on the FENCES Act (amending the Clean Air Act regarding foreign-origin transboundary emissions). |
C. Kentucky's 2nd Congressional District Baseline (Constituency Demographics & Economy)
- Population & Demographics: Population 765,661 (2024) [Fact 15, 24]; Median age: 39 years [Fact 1]; Non-Hispanic White: ~84%, Black: ~5.1%, Hispanic: ~4.6%, Multiracial: ~3.1% [Fact 23, 24].
- Socioeconomics: Median Household Income: $66,796 (National: $78,538; KY state: ~$60,000) [Fact 16, 24]; Poverty rate: 14.7% [Fact 24]; Homeownership rate: 70.4% [Fact 17, 24]; Median property value: $213,900 [Fact 21]; Bachelor’s degree or higher: 23.8% (vs. 33.7% national) [Fact 18, 24].
- Healthcare Dependency: Nearly 1 in 3 Kentuckians are enrolled in Medicaid statewide following ACA expansion [Fact 19, 45, 47]. Kentucky's uninsured rate declined from 14.3% pre-ACA to 5.9% post-ACA [Fact 45].
- Political Leaning: Strongly Republican; Donald Trump carried Kentucky statewide with 64.5% vs. Kamala Harris at 33.9% in 2024 [Fact 20, 24]. No incumbent has lost re-election in KY-2 since 1884; Guthrie has represented the seat since 2009 [Fact 24].
- District Referenda (2024): Amendment 1 (requiring U.S. citizenship to vote) passed 62.4% to 37.6% [Fact 13]. Amendment 2 (permitting state funding for private/charter schooling) failed ~65% to ~35%, losing in every Kentucky county [Fact 14].
- Dominant Industries & Employers: Dominant industries include Manufacturing (NAICS 31–33: automotive, aluminum, food processing), Healthcare/Social Assistance (NAICS 62), Educational Services (NAICS 61), and Public Administration/Defense (NAICS 92) [Fact 11, 12, 32, 33]. Top employers:
- Fort Knox: 22,000 employees [Fact 25]
- Houchens Industries: 5,467 employees [Fact 26]
- Med Center Health: 3,566 employees [Fact 27]
- Western Kentucky University: 1,854 employees [Fact 28]
- Dart Container Corporation: 1,600 employees [Fact 29]
- Logan Aluminum Inc.: 1,345 employees [Fact 30]
- GM Corvette Assembly Plant: 1,100 employees [Fact 31]
- Trace Die Cast Inc.: 540 employees [Fact 22]
2. KEY FINANCIAL & POLITICAL FLOWS
┌───────────────────────────────────────────────┐
│ HEALTH & CORPORATE PAC DONORS │
│ - Eli Lilly: $24,900 (2024) │
│ - Pharma Sector: $507,000 (2024 incumbent #1)│
│ - Health Career Total: $4.78M+ │
│ - ~100 New Corporate PACs post-Jan 2025 │
└───────────────────────┬───────────────────────┘
│
▼
┌───────────────────────────────────────────────┐
│ BRETT GUTHRIE CAMPAIGN COMMITTEE │
│ - Career Raised: $17,098,523 │
│ - 2023-2024: $3,829,928 (74% PAC / 1% Small) │
│ - Jan-Sep 2025 PAC haul: $1.6M │
└───────┬───────────────────────────────┬───────┘
│ │
$2.5M Outflow │ │ Legislative Authority:
(Over 50% spend) │ │ Chair, House Energy & Commerce
▼ ▼
┌───────────────────────────┐ ┌───────────────────────────┐
│ PARTY LEADERSHIP / │ │ POLICY & STATUTORY ACTS │
│ CAMPAIGN VEHICLE │ │ - H.R. 7174 (EPIC Act) │
│ NRCC ($2.5M transfer, │ │ - H.R. 1 ($880B Med Cuts) │
│ highest among chairs) │ │ - Clean Air Act revisions │
└───────────────────────────┘ └───────────────────────────┘
┌───────────────────────────────────────────────┐
│ FAMILY CAPITAL ASSET FLOWS │
│ SBA PPP Loans: $4.3M forgiven (2021) │
└───────────────────────┬───────────────────────┘
▼
┌───────────────────────────────────────────────┐
│ TRACE DIE CAST INC. │
│ - 540 employees in KY-2 │
│ - Board Member: Brett Guthrie (uncompensated)│
│ - Equity held: up to $10.5M │
│ - Trusts: $3M Guthrie Gift / $3M Lowell Trust│
└───────────────────────────────────────────────┘
Flow Breakdown
- Donor-to-Candidate Pipeline:
- Health and pharmaceutical entities constitute Guthrie's core financial base. Health Professionals ($2,090,252), Pharmaceuticals ($1,859,982), and HMOs/Health Services ($832,211) represent $4,782,445 (27.97%) of his $17.1M career receipts [Fact 3].
- In 2023–2024, Guthrie was structurally reliant on institutional donors: 74.09% ($2.84M) of funds came from PACs, whereas individual small donors contributed $38,277 (1.00%) [Fact 2].
- Chairmanship Surge (2025–2026):
- Upon assuming the House Energy and Commerce Committee gavel in January 2025, PAC funding increased by nearly 145% compared to the comparable 2023 period ($1.6 million vs. $651,800), with ~100 first-time corporate/special interest PACs contributing [Fact 34].
- Candidate-to-Party Funnel:
- Guthrie routed $2.5 million from his campaign account directly to the NRCC by Q1 2025, accounting for more than half of his committee's total outlays and the largest party transfer among 11 surveyed committee chairs [Fact 5].
- Federal Emergency Relief to Commercial Business:
- Guthrie maintained up to $10.5 million in equity and sat on the board of family enterprise Trace Die Cast Inc. while it secured $4.3 million in SBA PPP loan forgiveness [Fact 40].
3. NETWORK CONNECTIONS
The Central Hub: Brett Guthrie
Guthrie operates as a primary node bridging House leadership, federal healthcare regulation, party campaign apparatuses, and local manufacturing interests.
[NRCC]
▲
│ ($2.5M transfer)
│
[Pharma / Health PACs] ──► [BRETT GUTHRIE] ◄── [House Energy & Commerce Comm.]
(Pfizer, Lilly, Novo, │ │ (Gavel: Jan 2025; H.R. 1, H.R. 7174)
BCBS, Cencora, etc.) │ │
▼ ▼
[Trace Die Cast Inc.] [KY-2 District Economy]
(Up to $10.5M equity; (766k constituents; 1 in 3 on
$4.3M forgiven PPP) Medicaid; 14.7% poverty)
Strongest Documented Institutional Links
- House Leadership / Energy & Commerce Committee:
- Elevated to Chairman in January 2025. Committee holds direct jurisdiction over Medicaid, the Affordable Care Act, Clean Air Act, and pharmaceutical regulation under Medicare.
- National Republican Congressional Committee (NRCC):
- Anchored by Guthrie’s status as top transferor ($2.5M), establishing him as a crucial financier of the House Republican majority [Fact 5].
- Trace Die Cast Inc.:
- Guthrie family enterprise. Guthrie holds uncompensated board membership and equity valued between $3,000,000 (gift trust, 2018) and up to $10,500,000 total [Fact 6, 40]. Employs 540 people in KY-2 [Fact 22].
- Pharmaceutical Manufacturers & Major Health Insurers:
- Eli Lilly & Co ($24,900 in 2024 cycle) [Fact 35].
- Blue Cross/Blue Shield ($118,000 career) [Fact 36].
- Multiple recurring PAC donors across 2024 and 2026 cycles documented in database records: Cencora ($10,000), Gilead Sciences ($10,000), Fresenius ($10,000), CVS Health ($10,000), Takeda ($6,000), Alnylam ($8,000), Exact Sciences ($5,000), Novo Nordisk ($7,500), Boehringer Ingelheim ($7,500), Teva ($10,000), Alkermes ($10,000), BioMarin ($10,000), Pfizer ($5,000) [Documented Connections].
Traceable Local Corporate Links
- Houchens Industries: Second-largest employer in the district (5,467 employees) [Fact 26]; direct PAC contributor ($5,000 in 2024 cycle) [Documented Connections].
4. INFERENTIAL CLAIMS
Claim 1: Legislative Policy Alignment with Pharmaceutical Donors
- Inference: Representative Guthrie’s legislative priorities as Health Subcommittee leader and Energy & Commerce Chair—specifically sponsoring the EPIC Act (H.R. 7174) to shield small-molecule drugs from Medicare price negotiations and opposing the $35 insulin cap (H.R. 6833)—were advanced to protect the revenue streams of his principal campaign donors in the pharmaceutical sector.
- Confidence Level: Moderate-High.
- Basis: Guthrie accepted $507,000 in the 2024 cycle alone from the pharmaceuticals sector (ranking #1 among incumbents) and over $1.85 million over his career [Fact 3, 4, 44]. His introduction of H.R. 7174 occurred concurrently (January 2024) with his receipt of peak sector funding, directly addressing key statutory concerns of major pharmaceutical donors (such as Eli Lilly, his top corporate donor in 2024) [Fact 35, 43, 49].
Claim 2: Medicaid Policy Contradicts District Constituency Baseline
- Inference: Guthrie’s championship of the FY 2025 Budget Resolution and H.R. 1, which enacted $880 billion in Medicaid spending cuts projected to strip coverage from ~200,000 Kentuckians, runs counter to the baseline material interests of his constituents to satisfy national party leadership spending goals.
- Confidence Level: High.
- Basis: One in three Kentuckians relies on Medicaid, and the district suffers from a 14.7% poverty rate and lower-than-average median income ($66,796 vs. $78,538 national) [Fact 16, 19, 24, 48]. Simultaneously, Guthrie transferred a record $2.5 million to the NRCC and secured the Energy & Commerce Chairmanship, indicating prioritization of national conference standing over local healthcare safety nets [Fact 5, 34, 48].
Claim 3: Inconsistent Stances on Public Subsidies
- Inference: A policy inconsistency exists between Guthrie’s public posture against federal assistance to student debt holders and his family business's acceptance of federal balance-sheet relief.
- Confidence Level: High.
- Basis: Guthrie characterized federal student loan forgiveness as a "taxpayer-funded... bribe" [Fact 39]. In contrast, Trace Die Cast Inc.—in which Guthrie holds up to $10.5 million in personal equity and sits on the board—sought and received full forgiveness of $4.3 million in SBA taxpayer-funded emergency loans [Fact 40].
Claim 4: Environmental Deregulation and Family Business Interests
- Inference: Guthrie's floor vote in favor of H.R. 6409 (FENCES Act) to alter Clean Air Act standards advances the operational environment of his personal financial holding, Trace Die Cast Inc.
- Confidence Level: Moderate.
- Basis: Guthrie holds up to $10.5 million in equity in Trace Die Cast, an energy-intensive aluminum die-casting enterprise subject to EPA clean air regulations [Fact 10, 40]. However, the FENCES Act specifically targets emissions originating outside the United States; without facility-specific emissions data, the exact financial benefit to Trace Die Cast remains inferred rather than directly proven.
5. GAPS & CONTRADICTIONS
Gaps in the Current Dataset
- Exact Trace Die Cast Valuation Details:
- Congressional disclosure records provide ranges rather than precise values (e.g., "up to $10.5 million" in 2021 vs. $3,000,000 in the Brett Guthrie Gift Trust in 2018) [Fact 6, 40]. Post-2018 exact annual asset disclosure totals are absent from the primary facts.
- 2025–2026 Comprehensive Cycle Totals:
- While Q2 2025 raised $1.0 million and PAC funding from Jan–Sep 2025 totaled $1.6 million, the complete cycle-to-date receipts and disbursements leading up to October 2026 are not compiled [Fact 34, 37].
- Disposal / Allocation of NRCC Transfer Funds:
- The precise races or independent expenditure efforts funded by Guthrie’s $2.5 million NRCC transfer are not specified [Fact 5].
Contradictions in Public Record & Rhetoric
- "Protecting Vulnerable Americans" vs. Reconciliation Slashing:
- On July 3, 2025, Guthrie claimed on the House floor that H.R. 1 was crafted to "protect health care for our most vulnerable Americans" [Fact 41]. However, the bill directly executes $880 billion in Medicaid-focused reductions, with non-partisan projections showing ~200,000 Kentuckians and millions nationally losing health coverage [Fact 42, 48].
- Traditional Federalism vs. Local Interference:
- While Guthrie generally campaigns on conservative devolution and state autonomy, he voted for H.R. 5143 to override Washington, D.C.'s municipal policing standards, overriding local jurisdiction despite zero KY-2 constituent nexus [Fact 9].
6. RECOMMENDED RESEARCH DIRECTIONS
- Investigate Trace Die Cast EPA Compliance and Permitting:
- Target: Review EPA Enforcement and Compliance History Online (ECHO) database and Kentucky Division for Air Quality permits for Trace Die Cast’s Bowling Green facilities. Determine if federal Clean Air Act enforcement actions or Title V requirements align with legislation targeted by Guthrie’s committee.
- Examine 2025–2026 House Personal Financial Disclosures (PFDs):
- Target: Retrieve Guthrie's Calendar Year 2024 and 2025 Financial Disclosures filed with the Clerk of the House. Check whether the valuation of the Brett Guthrie Gift Trust or Lowell M. Guthrie Irrevocable Trust has changed following the $4.3M PPP forgiveness and subsequent manufacturing policy enactments.
- Trace E&C Committee Staff Revolving-Door Actions:
- Target: Cross-reference House Energy and Commerce Committee senior staff rosters (2025–2026) with LDA (Lobbying Disclosure Act) registrations, specifically targeting staff transitions to or from BGR Group, Eli Lilly, and PhRMA.
- Audit First-Time PAC Donors Post-Chairmanship:
- Target: Pull FEC Form 3X Schedule A filings for Guthrie's principal campaign committee from January 2025 to October 2026 to systematically identify the ~100 new corporate PACs and isolate corresponding committee legislative hearings or markups affecting those donors' market sectors.